Agilent Technologies, Inc. filed a Form 8-K with the SEC on September 8, 2026, disclosing that Board Chairperson Boon Hwee Koh retired from the Board effective September 4, 2026, and that Glenn Boehnlein was appointed to fill the resulting vacancy on the same date.

Key Highlights

  • Board Chair Retirement: Boon Hwee Koh notified the company on September 2, 2026 of his decision to retire from the Board, effective September 4, 2026, after 23 years of service.
  • No Disagreement: According to the filing, Mr. Koh's retirement "was not due to any disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices."
  • New Director Appointed: Glenn Boehnlein, age 64, was appointed as a Class III director effective September 4, 2026, upon the recommendation of the Nominating/Corporate Governance Committee.
  • Committee Assignments: Mr. Boehnlein was appointed to both the Audit and Finance Committee and the Compensation Committee, effective September 4, 2026.
  • Independence Determination: The Board determined that Mr. Boehnlein meets NYSE corporate governance independence standards and qualifies as an "audit committee financial expert" under Item 407(d)(5)(ii) of Regulation S-K.
  • Prior Experience: Mr. Boehnlein served as Vice President and Chief Financial Officer of Stryker Corporation from 2016 to 2025, and earlier as a partner at Arthur Andersen LLP.

Agilent Technologies Board Leadership Change: Koh Exits, Boehnlein Steps In

Agilent Technologies, Inc. (NYSE:A) disclosed a change in its board leadership through a current report filed September 8, 2026. Boon Hwee Koh, who had served as Chairperson of the Board, informed the company on September 2, 2026 that he would retire effective September 4, 2026. The filing states his departure was unrelated to any disagreement with the company or board on operations, policies, or practices. The company and board acknowledged his "23-year service on the Board."

To fill the vacancy, the Board appointed Glenn Boehnlein as a Class III director on September 4, 2026, acting on a recommendation from its Nominating/Corporate Governance Committee. Class III directors are scheduled to stand for re-election at the 2027 Annual Meeting of Stockholders, according to the filing. The Board simultaneously assigned Mr. Boehnlein to two committees: the Audit and Finance Committee and the Compensation Committee.

The filing describes Mr. Boehnlein's background as including more than two decades at Stryker Corporation, where he held several senior finance roles before serving as Vice President and Chief Financial Officer from 2016 to 2025. Earlier in his career, he was Chief Financial Officer of MyPrimeTime and a partner at Arthur Andersen LLP. He currently serves on the board of Inogen, Inc., where he chairs the Audit Committee, and on the board of Sutter Health. He holds bachelor's and master's degrees in professional accountancy from Mississippi State University. The filing states he will receive standard non-employee director compensation, pro-rated for his partial year of service, and will enter into a standard indemnification agreement with the company.

What Was Disclosed

Agilent Technologies reported the retirement of Board Chairperson Boon Hwee Koh after 23 years and the appointment of Glenn Boehnlein as a Class III director, effective September 4, 2026, with assignments to the Audit and Finance Committee and the Compensation Committee.